You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Costimulation

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allografts, Rejection; Transplant, Kidney, Transplant Rejection Trial in United States (Belatacept, VIB4920)

Active, not recruiting
  • Allografts
  • +3 more
  • Los Angeles, California
  • +3 more
Aug 11, 2022

Kidney Transplant Recipient Trial in Atlanta (Abatacept 125Mg/Ml Syringe)

Not yet recruiting
  • Kidney Transplant Recipient
  • Abatacept 125Mg/Ml Syringe
  • Atlanta, Georgia
  • +1 more
Aug 2, 2023

GVHD Trial in United States (Abatacept)

Recruiting
  • Graft Versus Host Disease
  • Birmingham, Alabama
  • +8 more
Mar 16, 2022

Kidney Transplantation, End Stage Kidney Disease (ESRD) Trial in Chicago (Belatacept Injection)

Recruiting
  • Kidney Transplantation
  • End Stage Kidney Disease (ESRD)
  • Belatacept Injection
  • Chicago, Illinois
    University of Chicago
May 13, 2022

Costimulation in Natural History and Therapeutic Outcome of

Active, not recruiting
  • Hepatitis B
    • San Francisco, California
    • +7 more
    Jul 30, 2021

    Costimulation in Natural History of Chronic Hepatitis B

    Active, not recruiting
    • Hepatitis B
      • San Francisco, California
      • +11 more
      Jul 30, 2021

      Highly Sensitized Prospective Kidney Transplant Recipients Trial in San Francisco (daratumumab, belatacept, Bone marrow

      Recruiting
      • Highly Sensitized Prospective Kidney Transplant Recipients
      • daratumumab
      • +2 more
      • San Francisco, California
        University of California at San Francisco Medical Center
      Jan 27, 2022

      Metastatic Melanoma, Skin Cancer Trial run by the NCI (Cyclophosphamide, Fludarabine, Aldesleukin)

      Terminated
      Has Results
      • Metastatic Melanoma
      • Skin Cancer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Nov 25, 2019

      Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)

      Active, not recruiting
      • Sickle Cell Disease
      • Graft Versus Host Disease
      • Washington, District of Columbia
      • +6 more
      Aug 4, 2021

      GVHD, Malignancy Trial in Canada, United States (Abatacept, )

      Active, not recruiting
      Has Results
      • Graft vs Host Disease
      • Malignancy
      • Los Angeles, California
      • +13 more
      Jan 9, 2023

      Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))

      Not yet recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Plasma Cell Leukemia
      • CAR-T (CAR-GPRC5D)
      • (no location specified)
      Feb 26, 2023

      Interstitial Lung Disease, Common Variable Immunodeficiency Trial in Cincinnati (Abatacept, Placebo)

      Recruiting
      • Interstitial Lung Disease
      • Common Variable Immunodeficiency
      • Rochester, Minnesota
      • +1 more
      Nov 18, 2022

      Metastatic Non Small Cell Lung Cancer Trial in Singapore (Nivolumab, ADG106)

      Recruiting
      • Metastatic Non Small Cell Lung Cancer
      • Singapore, Singapore
      • +1 more
      Mar 10, 2022

      Sensitisation, Highly Sensitised Dialysis Patients Trial in La Tronche (Each patient will undergo in the first step of the study

      Recruiting
      • Sensitisation
      • Highly Sensitised Dialysis Patients
      • Each patient will undergo in the first step of the study belatacept treatment and in the second apheresis and daratumumab
      • La Tronche, France
        Chu Grenoble
      May 12, 2022

      Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))

      Recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Plasma Cell Leukemia
      • CAR-T (CAR-GPRC5D)
      • Wuhan, Hu Bei, China
        Tongji Hospital, Tongji Medical College, Huazhong University of
      May 17, 2022

      Kidney Failure, Chronic, Renal Insufficiency Trial in Boston (drug, radiation, procedure)

      Completed
      Has Results
      • Kidney Failure, Chronic
      • Renal Insufficiency
      • Boston, Massachusetts
        Massachusetts General Hospital
      Oct 4, 2021

      Chronic Kidney Failure Trial in Nantes (Belatacept 250 Milligram Intravenous Powder for Solution)

      Not yet recruiting
      • Chronic Kidney Failure
      • Belatacept 250 Milligram Intravenous Powder for Solution
      • Nantes, Loire Atlantique, France
        CHU Nantes
      Sep 28, 2022

      Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

      Recruiting
      • Cancer
      • +4 more
      • INKmune
      • Athens, Attiki, Greece
      • +2 more
      Jul 3, 2023

      CMV Antiviral T-cell Immunity Over Next Six Months Initiation of

      Not yet recruiting
      • Kidney Transplant Infection
      • (no location specified)
      Jan 23, 2023

      Metabolic and Infectious Complications Post Belatacept

      Not yet recruiting
      • Kidney Transplant Infection
      • +3 more
      • Oral glucose tolerance test
      • (no location specified)
      Mar 29, 2022

      Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia Trial in Bergamo (Blinatumomab Expanded T-cells (BET))

      Active, not recruiting
      • Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
      • Blinatumomab Expanded T-cells (BET)
      • Bergamo, Italy
        ASST - Papa Giovanni XXIII
      Dec 22, 2021

      Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived

      Not yet recruiting
      • Islet Transplantation
      • Infusion of recipient T regulatory cell
      • Infusion of concomitant Donor Derived Vertebral Bone Marrow
      • Palo Alto, California
        Stanford University
      Jul 25, 2023

      Immunotherapy Trial in Xuzhou (CAR-T cell immunotherapy)

      Recruiting
      • Immunotherapy
      • CAR-T cell immunotherapy
      • Xuzhou, Jiangsu, China
        Affiliated Hospital of Xuzhou Medical University
      Jul 17, 2021

      Heart Transplant Failure Trial in France (Belatacept Injection)

      Recruiting
      • Heart Transplant Failure
      • Belatacept Injection
      • Bordeaux, France
      • +4 more
      Mar 24, 2022

      Organ Transplantation Trial in Atlanta (Belatacept, Sirolimus, Alemtuzumab)

      Completed
      Has Results
      • Organ Transplantation
      • Atlanta, Georgia
      • +1 more
      Jan 30, 2020